180 related articles for article (PubMed ID: 15726368)
1. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
Rodrigues DG; Maria DA; Fernandes DC; Valduga CJ; Couto RD; Ibañez OC; Maranhão RC
Cancer Chemother Pharmacol; 2005 Jun; 55(6):565-76. PubMed ID: 15726368
[TBL] [Abstract][Full Text] [Related]
2. Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide.
Valduga CJ; Fernandes DC; Lo Prete AC; Azevedo CH; Rodrigues DG; Maranhão RC
J Pharm Pharmacol; 2003 Dec; 55(12):1615-22. PubMed ID: 14738586
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
Dias ML; Carvalho JP; Rodrigues DG; Graziani SR; Maranhão RC
Cancer Chemother Pharmacol; 2007 Jan; 59(1):105-11. PubMed ID: 16699792
[TBL] [Abstract][Full Text] [Related]
4. Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion.
Lo Prete AC; Maria DA; Rodrigues DG; Valduga CJ; Ibañez OC; Maranhão RC
J Pharm Pharmacol; 2006 Jun; 58(6):801-8. PubMed ID: 16734981
[TBL] [Abstract][Full Text] [Related]
5. Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study.
Pires LA; Hegg R; Valduga CJ; Graziani SR; Rodrigues DG; Maranhão RC
Cancer Chemother Pharmacol; 2009 Jan; 63(2):281-7. PubMed ID: 18365196
[TBL] [Abstract][Full Text] [Related]
6. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.
Contente TC; Kretzer IF; Filippin-Monteiro FB; Maria DA; Maranhão RC
J Pharm Pharmacol; 2014 Dec; 66(12):1698-709. PubMed ID: 25131262
[TBL] [Abstract][Full Text] [Related]
7. Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma.
Azevedo CH; Carvalho JP; Valduga CJ; Maranhão RC
Gynecol Oncol; 2005 Apr; 97(1):178-82. PubMed ID: 15790455
[TBL] [Abstract][Full Text] [Related]
8. Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel.
Rodrigues DG; Covolan CC; Coradi ST; Barboza R; Maranhão RC
J Pharm Pharmacol; 2002 Jun; 54(6):765-72. PubMed ID: 12078992
[TBL] [Abstract][Full Text] [Related]
9. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.
Teixeira RS; Valduga CJ; Benvenutti LA; Schreier S; Maranhão RC
J Pharm Pharmacol; 2008 Oct; 60(10):1287-95. PubMed ID: 18812021
[TBL] [Abstract][Full Text] [Related]
10. Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE.
Pinheiro KV; Hungria VT; Ficker ES; Valduga CJ; Mesquita CH; Maranhão RC
Cancer Chemother Pharmacol; 2006 May; 57(5):624-30. PubMed ID: 16133527
[TBL] [Abstract][Full Text] [Related]
11. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE).
Teixeira RS; Curi R; Maranhão RC
J Pharm Pharmacol; 2004 Jul; 56(7):909-14. PubMed ID: 15233870
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC
Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
Mo Y; Lim LY
J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
[TBL] [Abstract][Full Text] [Related]
14. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
Lundberg BB
Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q
J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255
[TBL] [Abstract][Full Text] [Related]
17. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R
Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Kretzer IF; Maria DA; Guido MC; Contente TC; Maranhão RC
Int J Nanomedicine; 2016; 11():885-904. PubMed ID: 27022257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
